novel agents in multiple myeloma: considering toxicity and side effects
Published 7 years ago • 53 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
3:24
novel agents for the management of r/r myeloma
-
5:22
novel target antigens to improve the efficacy of immunotherapeutics in multiple myeloma
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
1:33
novel targets being explored in multiple myeloma and the value of celmods
-
2:09
integrating novel agents into the treatment of multiple myeloma
-
5:19
a 17-year fight against multiple myeloma
-
9:25
mgus diagnosis: a step-by-step approach
-
3:50
selinexor: a clear role in heavily pre-treated multiple myeloma
-
2:48
novel targets in multiple myeloma
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:18
how will novel agents be sequenced for patients with multiple myeloma?
-
2:42
hdac8: a novel therapeutic target in multiple myeloma
-
1:25
predictors and outcomes of extramedullary disease in multiple myeloma
-
13:23
novel therapeutics in multiple myeloma
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:19
the importance of novel targets in myeloma
-
2:13
novel agents in development for multiple myeloma: celmods, antibody-drug conjugates, and peptides
-
5:25
novel immunotherapies for multiple myeloma
-
2:44
myeloma qol through induction and maintenance
-
2:56
novel drugs for myeloma thromboprophylaxis